PSTX

Poseida Therapeutics, Inc.CIK 1661460 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for PSTX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for PSTX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Rizvi Syed Ali-aamir	Chief Medical Officer	4	$0	$0	2025-01-08
Corning Luke	Director	12	$0	$0	2025-01-08
Yarema Kristin	President, Cell Therapy	7	$0	$0	2025-01-08
Mylet Johanna	Senior Vice President, Finance	27	$0	$0	2025-01-08
Malin Life Sciences Holdings Ltd	10% Owner	14	$11.07M	$0	2025-01-08
Amado Rafael	Director	7	$0	$0	2025-01-08
BAUM CHARLES M	Director	10	$0	$0	2025-01-08
Schmid John P.	Director	18	$0	$0	2025-01-08
Collins Cynthia	Director	12	$0	$0	2025-01-08
Lloyd Marcea Bland	Director	19	$160.0K	$0	2025-01-08
Gergen Mark J	President and CEO	26	$0	$561.9K	2025-01-08
LEONHARDT HARRY J	GC & Chief Compliance Officer	15	$0	$0	2025-01-08
Warner Brent	President, Gene Therapy	8	$0	$0	2024-03-01
Ostertag Eric	Executive Chairman	70	$500.0K	$7.95M	2023-02-01
Ingalls Kerry D.	Chief Operating Officer	5	$25.9K	$0	2022-03-16
Spear Matthew A.	Chief Medical Officer	26	$0	$106.7K	2022-03-01
Hirsch David	Director	7	$4.00M	$0	2021-07-23
Murphy Sean	Director, 10% Owner	10	$160.0K	$0	2020-07-14
Malin Corp plc	10% Owner	8	$0	$0	2020-07-14
NOVARTIS AG	10% Owner	2	$0	$0	2020-07-14
MACKEY CATHERINE J	Director	1	$0	$0	2020-07-09
Francis, John P.	Director	2	$0	$0	2014-03-24
Stewart Brian	President & CEO	5	$0	$0	2014-03-24
DREYER DAVID C	Chief Financial Officer	5	$0	$0	2014-03-24
CLEARMAN STEPHEN J	10% Owner	2	$0	$4.18M	2014-01-10

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Yarema Kristin	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	498,325	—	$0	0	SEC↗
Yarema Kristin	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	345,200	—	$0	0	SEC↗
Gergen Mark J	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	342,000	—	$0	0	SEC↗
Gergen Mark J	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	75,000	—	$0	0	SEC↗
Gergen Mark J	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	364,060	—	$0	0	SEC↗
Gergen Mark J	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	518,500	—	$0	0	SEC↗
Gergen Mark J	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	48,115	—	$0	0	SEC↗
Gergen Mark J	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	172,600	—	$0	0	SEC↗
Gergen Mark J	President and CEO	D To issuer deriv	2025-01-08	2025-01-08	240,721	—	$0	0	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	D To issuer deriv	2025-01-08	2025-01-08	111,700	—	$0	0	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	D To issuer deriv	2025-01-08	2025-01-08	125,283	—	$0	0	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	D To issuer deriv	2025-01-08	2025-01-08	72,568	—	$0	0	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	D To issuer deriv	2025-01-08	2025-01-08	137,000	—	$0	0	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	D To issuer deriv	2025-01-08	2025-01-08	160,385	—	$0	0	SEC↗
Rizvi Syed Ali-aamir	Chief Medical Officer	D To issuer deriv	2025-01-08	2025-01-08	250,000	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	D To issuer deriv	2025-01-08	2025-01-08	35,000	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	D To issuer deriv	2025-01-08	2025-01-08	4,117	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	D To issuer deriv	2025-01-08	2025-01-08	80,192	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	D To issuer deriv	2025-01-08	2025-01-08	82,000	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	D To issuer deriv	2025-01-08	2025-01-08	111,700	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	D To issuer deriv	2025-01-08	2025-01-08	125,283	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	D To issuer deriv	2025-01-08	2025-01-08	72,568	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	D To issuer deriv	2025-01-08	2025-01-08	65,000	—	$0	0	SEC↗
BAUM CHARLES M	Director	D To issuer deriv	2025-01-08	2025-01-08	57,000	—	$0	0	SEC↗
BAUM CHARLES M	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
BAUM CHARLES M	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Collins Cynthia	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Collins Cynthia	Director	D To issuer deriv	2025-01-08	2025-01-08	87,440	—	$0	0	SEC↗
Collins Cynthia	Director	D To issuer deriv	2025-01-08	2025-01-08	28,500	—	$0	0	SEC↗
Collins Cynthia	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	D To issuer deriv	2025-01-08	2025-01-08	25,833	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	D To issuer deriv	2025-01-08	2025-01-08	32,076	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	D To issuer deriv	2025-01-08	2025-01-08	16,038	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	D To issuer deriv	2025-01-08	2025-01-08	20,000	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	D To issuer deriv	2025-01-08	2025-01-08	20,000	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	D To issuer deriv	2025-01-08	2025-01-08	28,500	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Schmid John P.	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Schmid John P.	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Schmid John P.	Director	D To issuer deriv	2025-01-08	2025-01-08	16,038	—	$0	0	SEC↗
Schmid John P.	Director	D To issuer deriv	2025-01-08	2025-01-08	20,000	—	$0	0	SEC↗
Schmid John P.	Director	D To issuer deriv	2025-01-08	2025-01-08	20,000	—	$0	0	SEC↗
Schmid John P.	Director	D To issuer deriv	2025-01-08	2025-01-08	25,833	—	$0	0	SEC↗
Schmid John P.	Director	D To issuer deriv	2025-01-08	2025-01-08	32,076	—	$0	0	SEC↗
Schmid John P.	Director	D To issuer deriv	2025-01-08	2025-01-08	28,500	—	$0	0	SEC↗
Corning Luke	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Corning Luke	Director	D To issuer deriv	2025-01-08	2025-01-08	28,500	—	$0	0	SEC↗
Corning Luke	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Corning Luke	Director	D To issuer deriv	2025-01-08	2025-01-08	45,833	—	$0	0	SEC↗
Amado Rafael	Director	D To issuer deriv	2025-01-08	2025-01-08	55,200	—	$0	0	SEC↗
Amado Rafael	Director	D To issuer deriv	2025-01-08	2025-01-08	27,350	—	$0	0	SEC↗
Yarema Kristin	President and CEO	U Tender	2025-01-08	2025-01-08	615,836	—	$0	0	SEC↗
Gergen Mark J	President and CEO	U Tender	2025-01-08	2025-01-08	636,726	—	$0	0	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	U Tender	2025-01-08	2025-01-08	223,640	—	$0	0	SEC↗
Rizvi Syed Ali-aamir	Chief Medical Officer	U Tender	2025-01-08	2025-01-08	185,000	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	U Tender	2025-01-08	2025-01-08	254,852	—	$0	0	SEC↗
BAUM CHARLES M	Director	U Tender	2025-01-08	2025-01-08	78,600	—	$0	0	SEC↗
Collins Cynthia	Director	U Tender	2025-01-08	2025-01-08	58,950	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	U Tender	2025-01-08	2025-01-08	68,950	—	$0	0	SEC↗
Schmid John P.	Director	U Tender	2025-01-08	2025-01-08	58,950	—	$0	0	SEC↗
Corning Luke	Director	U Tender	2025-01-08	2025-01-08	58,950	—	$0	0	SEC↗
Amado Rafael	Director	U Tender	2025-01-08	2025-01-08	58,950	—	$0	0	SEC↗
Malin Life Sciences Holdings L	10% Owner	U Tender	2025-01-08	2025-01-10	11,835,673	—	$0	0	SEC↗
Gergen Mark J	Executive Chairman	F Tax w/h	2025-01-02	2025-01-03	23,313	$9.60	$223.8K	630,726	SEC↗
Gergen Mark J	Executive Chairman	M Exercise deriv	2024-12-10	2024-12-11	30,000	—	$0	96,372	SEC↗
Gergen Mark J	Executive Chairman	S Sale	2024-12-10	2024-12-11	30,000	$9.46	$283.8K	651,291	SEC↗
Gergen Mark J	Executive Chairman	M Exercise	2024-12-10	2024-12-11	30,000	$2.78	$83.4K	681,291	SEC↗
Gergen Mark J	Executive Chairman	M Exercise deriv	2024-11-26	2024-11-27	30,000	—	$0	126,372	SEC↗
Gergen Mark J	Executive Chairman	M Exercise	2024-11-26	2024-11-27	30,000	$2.78	$83.4K	681,291	SEC↗
Gergen Mark J	Executive Chairman	S Sale	2024-11-26	2024-11-27	30,000	$9.27	$278.1K	651,291	SEC↗
Amado Rafael	Director	A Award deriv	2024-06-17	2024-06-18	27,350	—	$0	27,350	SEC↗
BAUM CHARLES M	Director	A Award deriv	2024-06-17	2024-06-18	27,350	—	$0	27,350	SEC↗
Collins Cynthia	Director	A Award deriv	2024-06-17	2024-06-18	27,350	—	$0	27,350	SEC↗
Corning Luke	Director	A Award deriv	2024-06-17	2024-06-18	27,350	—	$0	27,350	SEC↗
Lloyd Marcea Bland	Director	A Award deriv	2024-06-17	2024-06-18	27,350	—	$0	27,350	SEC↗
Schmid John P.	Director	A Award deriv	2024-06-17	2024-06-18	27,350	—	$0	27,350	SEC↗
Amado Rafael	Director	A Award	2024-06-17	2024-06-18	19,650	—	$0	58,950	SEC↗
BAUM CHARLES M	Director	A Award	2024-06-17	2024-06-18	19,650	—	$0	78,600	SEC↗
Collins Cynthia	Director	A Award	2024-06-17	2024-06-18	19,650	—	$0	58,950	SEC↗
Corning Luke	Director	A Award	2024-06-17	2024-06-18	19,650	—	$0	58,950	SEC↗
Lloyd Marcea Bland	Director	A Award	2024-06-17	2024-06-18	19,650	—	$0	68,950	SEC↗
Schmid John P.	Director	A Award	2024-06-17	2024-06-18	19,650	—	$0	58,950	SEC↗
Rizvi Syed Ali-aamir	Chief Medical Officer	A Award deriv	2024-04-01	2024-04-03	250,000	—	$0	250,000	SEC↗
Rizvi Syed Ali-aamir	Chief Medical Officer	A Award	2024-04-01	2024-04-03	185,000	—	$0	185,000	SEC↗
Warner Brent	President, Gene Therapy	A Award deriv	2024-03-01	2024-03-04	111,700	—	$0	111,700	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	A Award deriv	2024-03-01	2024-03-04	111,700	—	$0	111,700	SEC↗
Mylet Johanna	Chief Financial Officer	A Award deriv	2024-03-01	2024-03-04	111,700	—	$0	111,700	SEC↗
Warner Brent	President, Gene Therapy	A Award	2024-03-01	2024-03-04	80,743	—	$0	454,779	SEC↗
Warner Brent	President, Gene Therapy	F Tax w/h	2024-03-01	2024-03-04	35,739	$4.13	$147.6K	419,040	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	F Tax w/h	2024-03-01	2024-03-04	16,306	$4.13	$67.3K	214,640	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	A Award	2024-03-01	2024-03-04	80,743	—	$0	230,946	SEC↗
Gergen Mark J	Executive Chairman	F Tax w/h	2024-03-01	2024-03-04	34,157	$4.13	$141.1K	651,291	SEC↗
Mylet Johanna	Chief Financial Officer	F Tax w/h	2024-03-01	2024-03-04	18,091	$4.13	$74.7K	246,283	SEC↗
Mylet Johanna	Chief Financial Officer	A Award	2024-03-01	2024-03-04	80,743	—	$0	264,374	SEC↗
Gergen Mark J	Executive Chairman	F Tax w/h	2024-02-01	2024-02-02	47,162	$3.41	$160.8K	685,448	SEC↗
Gergen Mark J	Executive Chairman	A Award deriv	2024-01-02	2024-01-04	172,600	—	$0	172,600	SEC↗
Yarema Kristin	President and CEO	A Award deriv	2024-01-02	2024-01-04	345,200	—	$0	345,200	SEC↗
Gergen Mark J	Executive Chairman	A Award	2024-01-02	2024-01-04	125,000	—	$0	732,610	SEC↗
Yarema Kristin	President and CEO	A Award	2024-01-02	2024-01-04	250,000	—	$0	606,836	SEC↗
Corning Luke	Director	A Award deriv	2023-06-15	2023-06-16	27,350	—	$0	27,350	SEC↗
BAUM CHARLES M	Director	A Award deriv	2023-06-15	2023-06-16	27,350	—	$0	27,350	SEC↗
Lloyd Marcea Bland	Director	A Award deriv	2023-06-15	2023-06-16	27,350	—	$0	27,350	SEC↗
Schmid John P.	Director	A Award deriv	2023-06-15	2023-06-16	27,350	—	$0	27,350	SEC↗
Collins Cynthia	Director	A Award deriv	2023-06-15	2023-06-16	27,350	—	$0	27,350	SEC↗
Corning Luke	Director	A Award	2023-06-15	2023-06-16	19,650	—	$0	39,300	SEC↗
BAUM CHARLES M	Director	A Award	2023-06-15	2023-06-16	19,650	—	$0	58,950	SEC↗
Lloyd Marcea Bland	Director	A Award	2023-06-15	2023-06-16	19,650	—	$0	49,300	SEC↗
Schmid John P.	Director	A Award	2023-06-15	2023-06-16	19,650	—	$0	39,300	SEC↗
Collins Cynthia	Director	A Award	2023-06-15	2023-06-16	19,650	—	$0	39,300	SEC↗
Amado Rafael	Director	A Award deriv	2023-05-01	2023-05-02	55,200	—	$0	55,200	SEC↗
Amado Rafael	Director	A Award	2023-05-01	2023-05-02	39,300	—	$0	39,300	SEC↗
Yarema Kristin	President, Cell Therapy	A Award deriv	2023-04-11	2023-04-12	498,325	—	$0	498,325	SEC↗
Yarema Kristin	President, Cell Therapy	A Award	2023-04-11	2023-04-12	356,836	—	$0	356,836	SEC↗
Gergen Mark J	President and CEO	A Award deriv	2023-03-01	2023-03-02	364,060	—	$0	364,060	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	A Award deriv	2023-03-01	2023-03-02	125,283	—	$0	125,283	SEC↗
Mylet Johanna	Chief Financial Officer	A Award deriv	2023-03-01	2023-03-02	125,283	—	$0	125,283	SEC↗
Warner Brent	President, Gene Therapy	A Award deriv	2023-03-01	2023-03-02	125,283	—	$0	125,283	SEC↗
Gergen Mark J	President and CEO	A Award	2023-03-01	2023-03-02	269,586	—	$0	601,610	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	A Award	2023-03-01	2023-03-02	92,772	—	$0	148,526	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	F Tax w/h	2023-03-01	2023-03-02	4,323	$5.35	$23.1K	144,203	SEC↗
Mylet Johanna	Chief Financial Officer	F Tax w/h	2023-03-01	2023-03-02	4,323	$5.35	$23.1K	177,631	SEC↗
Mylet Johanna	Chief Financial Officer	A Award	2023-03-01	2023-03-02	92,772	—	$0	181,954	SEC↗
Warner Brent	President, Gene Therapy	F Tax w/h	2023-03-01	2023-03-02	26,617	$5.35	$142.4K	374,036	SEC↗
Warner Brent	President, Gene Therapy	A Award	2023-03-01	2023-03-02	92,772	—	$0	400,653	SEC↗
Gergen Mark J	President and CEO	F Tax w/h	2023-02-01	2023-02-03	31,819	$7.00	$222.7K	330,314	SEC↗
Ostertag Eric	Director	F Tax w/h	2023-02-01	2023-02-03	11,776	$7.00	$82.4K	827,320	SEC↗
Ostertag Eric	Executive Chairman	P Buy	2022-08-08	2022-08-10	142,857	$3.50	$500.0K	838,824	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2022-08-08	2022-08-10	2,150,000	$3.50	$7.53M	11,835,673	SEC↗
Ostertag Eric	Executive Chairman	S Sale	2022-08-03	2022-08-05	160,696	$3.69	$593.0K	0	SEC↗
Lloyd Marcea Bland	Director	A Award deriv	2022-06-16	2022-06-16	28,500	—	$0	28,500	SEC↗
Schmid John P.	Director	A Award deriv	2022-06-16	2022-06-16	28,500	—	$0	28,500	SEC↗
Corning Luke	Director	A Award deriv	2022-06-16	2022-06-16	28,500	—	$0	28,500	SEC↗
BAUM CHARLES M	Director	A Award deriv	2022-06-16	2022-06-16	57,000	—	$0	57,000	SEC↗
Collins Cynthia	Director	A Award deriv	2022-06-16	2022-06-17	28,500	—	$0	28,500	SEC↗
Lloyd Marcea Bland	Director	A Award	2022-06-16	2022-06-16	19,650	—	$0	29,650	SEC↗
Schmid John P.	Director	A Award	2022-06-16	2022-06-16	19,650	—	$0	19,650	SEC↗
Corning Luke	Director	A Award	2022-06-16	2022-06-16	19,650	—	$0	19,650	SEC↗
BAUM CHARLES M	Director	A Award	2022-06-16	2022-06-16	39,300	—	$0	39,300	SEC↗
Collins Cynthia	Director	A Award	2022-06-16	2022-06-17	19,650	—	$0	19,650	SEC↗
Ingalls Kerry D.	Chief Operating Officer	P Buy	2022-03-16	2022-03-18	3,000	$3.98	$11.9K	55,000	SEC↗
Warner Brent	President, Gene Therapy	A Award deriv	2022-03-01	2022-03-01	431,034	—	$0	431,034	SEC↗
Spear Matthew A.	Chief Medical Officer	A Award deriv	2022-03-01	2022-03-01	72,568	—	$0	72,568	SEC↗
Mylet Johanna	Chief Financial Officer	A Award deriv	2022-03-01	2022-03-01	72,568	—	$0	72,568	SEC↗
Ingalls Kerry D.	Chief Operating Officer	A Award deriv	2022-03-01	2022-03-01	72,568	—	$0	72,568	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	A Award deriv	2022-03-01	2022-03-01	72,568	—	$0	72,568	SEC↗
Warner Brent	President, Gene Therapy	A Award	2022-03-01	2022-03-01	307,881	—	$0	307,881	SEC↗
Spear Matthew A.	Chief Medical Officer	A Award	2022-03-01	2022-03-01	50,000	—	$0	111,485	SEC↗
Mylet Johanna	Chief Financial Officer	A Award	2022-03-01	2022-03-01	50,000	—	$0	84,231	SEC↗
Ingalls Kerry D.	Chief Operating Officer	A Award	2022-03-01	2022-03-01	50,000	—	$0	52,000	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	A Award	2022-03-01	2022-03-01	50,000	—	$0	50,000	SEC↗
Ostertag Eric	Executive Chairman	A Award deriv	2022-02-01	2022-02-01	10,792	—	$0	10,792	SEC↗
Ostertag Eric	Executive Chairman	A Award deriv	2022-02-01	2022-02-01	118,708	—	$0	118,708	SEC↗
Gergen Mark J	President and CEO	A Award deriv	2022-02-01	2022-02-01	518,500	—	$0	518,500	SEC↗
Ostertag Eric	Executive Chairman	A Award	2022-02-01	2022-02-01	89,500	—	$0	692,967	SEC↗
Gergen Mark J	President and CEO	A Award	2022-02-01	2022-02-01	357,200	—	$0	357,200	SEC↗
Ostertag Eric	Executive Chairman	G Gift	2021-12-30	2022-02-01	48,902	—	$0	580,292	SEC↗
Ostertag Eric	Executive Chairman	G Gift	2021-12-30	2022-02-01	93,955	—	$0	603,467	SEC↗
Mylet Johanna	Chief Financial Officer	M Exercise deriv	2021-12-21	2021-12-22	3,100	—	$0	3,816	SEC↗
Mylet Johanna	Chief Financial Officer	M Exercise deriv	2021-12-21	2021-12-22	2,616	—	$0	0	SEC↗
Mylet Johanna	Chief Financial Officer	M Exercise	2021-12-21	2021-12-22	3,100	$1.93	$6.0K	34,231	SEC↗
Mylet Johanna	Chief Financial Officer	M Exercise	2021-12-21	2021-12-22	2,616	$1.17	$3.1K	31,131	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-12-06	2021-12-08	10,000	—	$0	70,861	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-12-06	2021-12-07	1,828	$6.90	$12.6K	9,685,673	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-12-06	2021-12-08	10,000	$1.32	$13.2K	61,485	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-12-02	2021-12-02	4,296	$6.88	$29.6K	9,683,845	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-12-01	2021-12-02	18,365	$6.85	$125.8K	9,679,549	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-30	2021-12-02	28,592	$6.85	$195.9K	9,661,184	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-29	2021-11-29	11,057	$6.89	$76.2K	9,632,592	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-26	2021-11-29	27,251	$6.81	$185.6K	9,621,535	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-24	2021-11-29	1,054	$6.89	$7.3K	9,594,284	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-23	2021-11-23	14,625	$6.77	$99.0K	9,593,230	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise deriv	2021-11-19	2021-11-22	1,000	—	$0	739,995	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise	2021-11-19	2021-11-22	1,000	$9.15	$9.2K	697,422	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-19	2021-11-23	11,104	$7.44	$82.6K	9,578,605	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-18	2021-11-18	71,312	$7.18	$512.0K	9,567,501	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-17	2021-11-18	280,384	$7.21	$2.02M	9,496,189	SEC↗
Ingalls Kerry D.	Chief Operating Officer	P Buy	2021-11-17	2021-11-18	2,000	$7.00	$14.0K	2,000	SEC↗
Malin Life Sciences Holdings L	10% Owner	P Buy	2021-11-16	2021-11-18	27,680	$7.17	$198.5K	9,215,805	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-11-08	2021-11-10	9,873	$7.09	$70.0K	3,659,503	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-11-08	2021-11-10	9,051	$7.09	$64.2K	3,358,455	SEC↗
Mylet Johanna	Chief Financial Officer	A Award deriv	2021-11-01	2021-11-02	65,000	—	$0	65,000	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise deriv	2021-10-11	2021-10-13	18,525	—	$0	740,995	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise	2021-10-11	2021-10-13	18,525	$9.15	$169.5K	696,422	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-10-01	2021-10-05	10,450	$7.02	$73.4K	3,669,376	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-10-01	2021-10-05	9,579	$7.02	$67.2K	3,367,506	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-09-20	2021-09-22	20,000	$8.00	$160.0K	160,696	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-09-14	2021-09-15	20,000	$8.14	$162.8K	180,696	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise deriv	2021-09-13	2021-09-15	2,757	—	$0	0	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise deriv	2021-09-13	2021-09-15	18,524	—	$0	759,520	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise	2021-09-13	2021-09-15	18,524	$9.15	$169.5K	675,415	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise	2021-09-13	2021-09-15	2,757	$1.17	$3.2K	656,891	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-09-09	2021-09-10	10,000	—	$0	80,861	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-09-09	2021-09-10	10,000	$1.32	$13.2K	51,485	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-09-02	2021-09-03	31,963	$8.34	$266.6K	3,679,826	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-09-02	2021-09-03	29,299	$8.34	$244.4K	3,377,085	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-09-01	2021-09-03	24,463	$8.46	$207.0K	3,406,384	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-09-01	2021-09-03	26,686	$8.46	$225.8K	3,711,789	SEC↗
Corning Luke	Director	A Award deriv	2021-08-25	2021-08-27	45,833	—	$0	45,833	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-08-20	2021-08-24	4,000	—	$0	90,861	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-08-20	2021-08-24	4,000	$1.32	$5.3K	45,485	SEC↗
Spear Matthew A.	Chief Medical Officer	S Sale	2021-08-20	2021-08-24	4,000	$8.79	$35.2K	41,485	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise deriv	2021-08-06	2021-08-10	111,149	—	$0	778,044	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise	2021-08-06	2021-08-10	111,149	$9.15	$1.02M	654,134	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-08-03	2021-08-04	10,401	$7.99	$83.1K	3,738,475	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-08-03	2021-08-04	9,535	$7.99	$76.2K	3,430,847	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-08-02	2021-08-04	7,167	$8.13	$58.3K	3,748,876	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-08-02	2021-08-04	6,570	$8.13	$53.4K	3,440,382	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-07-28	2021-07-30	20,000	—	$0	94,861	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-07-28	2021-07-30	20,000	$1.32	$26.4K	41,485	SEC↗
Collins Cynthia	Director	A Award deriv	2021-07-23	2021-07-26	87,440	—	$0	87,440	SEC↗
Hirsch David	Director	A Award deriv	2021-07-23	2021-07-26	25,833	—	$0	25,833	SEC↗
Lloyd Marcea Bland	Director	A Award deriv	2021-07-23	2021-07-26	25,833	—	$0	25,833	SEC↗
Schmid John P.	Director	A Award deriv	2021-07-23	2021-07-26	25,833	—	$0	25,833	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-07-02	2021-07-06	13,076	$8.90	$116.4K	3,446,952	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-07-02	2021-07-06	104	$9.65	$1.0K	3,770,309	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-07-02	2021-07-06	14,266	$8.90	$127.0K	3,756,043	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-07-02	2021-07-06	96	$9.65	$926	3,460,028	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-07-01	2021-07-06	10,729	$9.77	$104.8K	3,770,413	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-07-01	2021-07-06	9,834	$9.77	$96.1K	3,460,124	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-06-17	2021-06-21	5,000	—	$0	114,861	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-06-17	2021-06-21	5,000	$1.32	$6.6K	21,485	SEC↗
Hirsch David	Director	A Award deriv	2021-06-16	2021-06-17	20,000	—	$0	20,000	SEC↗
Schmid John P.	Director	A Award deriv	2021-06-16	2021-06-17	20,000	—	$0	20,000	SEC↗
Lloyd Marcea Bland	Director	A Award deriv	2021-06-16	2021-06-17	20,000	—	$0	20,000	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-06-11	2021-06-14	4,000	—	$0	119,861	SEC↗
Spear Matthew A.	Chief Medical Officer	S Sale	2021-06-11	2021-06-14	4,000	$9.44	$37.8K	16,485	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-06-11	2021-06-14	4,000	$1.32	$5.3K	20,485	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-06-02	2021-06-03	19,476	$8.34	$162.4K	3,469,958	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-06-02	2021-06-03	21,246	$8.34	$177.2K	3,781,142	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-06-01	2021-06-03	19,701	$8.61	$169.6K	3,489,434	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-06-01	2021-06-03	21,493	$8.61	$185.1K	3,802,388	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-05-04	2021-05-05	18,775	$8.44	$158.5K	3,823,881	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-05-04	2021-05-05	17,211	$8.44	$145.3K	3,509,135	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-05-03	2021-05-05	8,765	$9.01	$79.0K	3,526,346	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-05-03	2021-05-05	9,561	$9.01	$86.1K	3,842,656	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-04-23	2021-04-23	5,000	—	$0	123,861	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-04-23	2021-04-23	5,000	$1.32	$6.6K	16,485	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-04-21	2021-04-23	4,000	—	$0	128,861	SEC↗
Spear Matthew A.	Chief Medical Officer	S Sale	2021-04-21	2021-04-23	4,000	$8.44	$33.8K	11,485	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-04-21	2021-04-23	4,000	$1.32	$5.3K	15,485	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-04-05	2021-04-05	1,617	$10.32	$16.7K	3,852,217	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-04-05	2021-04-05	1,483	$10.32	$15.3K	3,532,624	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-04-05	2021-04-05	26,170	$9.63	$252.0K	3,534,107	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-04-05	2021-04-05	28,549	$9.63	$274.9K	3,853,834	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-04-01	2021-04-05	29,834	$9.55	$284.9K	3,882,383	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-04-01	2021-04-05	27,347	$9.55	$261.2K	3,560,277	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-03-02	2021-03-03	27,290	$11.54	$314.9K	3,590,111	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-03-02	2021-03-03	29,770	$11.54	$343.5K	3,912,217	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-03-01	2021-03-03	484	$12.12	$5.9K	3,617,401	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-03-01	2021-03-03	27,226	$11.66	$317.5K	3,617,885	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-03-01	2021-03-03	528	$12.12	$6.4K	3,941,987	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-03-01	2021-03-03	29,702	$11.66	$346.3K	3,942,515	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise deriv	2021-02-23	2021-02-25	111,395	—	$0	2,757	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise	2021-02-23	2021-02-25	111,395	$1.17	$130.3K	542,985	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-02-16	2021-02-17	133,149	$10.00	$1.33M	200,696	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise deriv	2021-02-10	2021-02-12	67,534	—	$0	0	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-02-10	2021-02-12	12,389	$10.00	$123.9K	333,845	SEC↗
Ostertag Eric	Chief Executive Officer	M Exercise	2021-02-10	2021-02-12	67,534	$1.29	$87.1K	431,590	SEC↗
Ostertag Eric	Chief Executive Officer	A Award deriv	2021-02-04	2021-02-05	889,193	—	$0	889,193	SEC↗
Gergen Mark J	President and CBO	A Award deriv	2021-02-04	2021-02-05	342,000	—	$0	342,000	SEC↗
Spear Matthew A.	Chief Medical Officer	A Award deriv	2021-02-04	2021-02-05	164,000	—	$0	164,000	SEC↗
Ingalls Kerry D.	Chief Operating Officer	A Award deriv	2021-02-04	2021-02-05	137,000	—	$0	137,000	SEC↗
LEONHARDT HARRY J	GC & Chief Compliance Office	A Award deriv	2021-02-04	2021-02-05	137,000	—	$0	137,000	SEC↗
Mylet Johanna	Senior Vice President, Finan	A Award deriv	2021-02-04	2021-02-05	82,000	—	$0	82,000	SEC↗
Ostertag Eric	Chief Executive Officer	S Sale	2021-01-21	2021-01-25	4,462	$10.00	$44.6K	346,234	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-01-15	2021-01-19	7,564	—	$0	132,861	SEC↗
Mylet Johanna	Senior Vice President, Finan	M Exercise deriv	2021-01-15	2021-01-19	551	—	$0	0	SEC↗
Mylet Johanna	Senior Vice President, Finan	M Exercise deriv	2021-01-15	2021-01-19	4,177	—	$0	0	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-01-15	2021-01-19	7,564	$1.32	$10.0K	11,485	SEC↗
Mylet Johanna	Senior Vice President, Finan	M Exercise	2021-01-15	2021-01-19	4,728	$0.30	$1.4K	26,813	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise deriv	2021-01-08	2021-01-11	3,921	—	$0	140,425	SEC↗
Spear Matthew A.	Chief Medical Officer	M Exercise	2021-01-08	2021-01-11	3,921	$1.32	$5.2K	3,921	SEC↗
Hirsch David	Director	C Conversion deriv	2020-07-14	2020-07-15	491,159	—	$0	0	SEC↗
Hirsch David	Director	C Conversion deriv	2020-07-14	2020-07-15	2,581,755	—	$0	0	SEC↗
Murphy Sean	Director, 10% Owner	C Conversion deriv	2020-07-14	2020-07-15	8,746,356	—	$0	0	SEC↗
Murphy Sean	Director, 10% Owner	C Conversion deriv	2020-07-14	2020-07-15	1,457,725	—	$0	0	SEC↗
Murphy Sean	Director, 10% Owner	C Conversion deriv	2020-07-14	2020-07-15	860,585	—	$0	0	SEC↗
Murphy Sean	Director, 10% Owner	C Conversion deriv	2020-07-14	2020-07-15	392,927	—	$0	0	SEC↗
Ostertag Eric	Chief Executive Officer	C Conversion deriv	2020-07-14	2020-07-15	319,039	—	$0	0	SEC↗
Ostertag Eric	Chief Executive Officer	C Conversion deriv	2020-07-14	2020-07-15	437,318	—	$0	0	SEC↗
Malin Corp plc	10% Owner	C Conversion deriv	2020-07-14	2020-07-15	860,585	—	$0	0	SEC↗
Malin Corp plc	10% Owner	C Conversion deriv	2020-07-14	2020-07-15	392,927	—	$0	0	SEC↗
Malin Corp plc	10% Owner	C Conversion deriv	2020-07-14	2020-07-15	1,457,725	—	$0	0	SEC↗
Malin Corp plc	10% Owner	C Conversion deriv	2020-07-14	2020-07-15	8,746,356	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2020-07-14	2020-07-16	7,367,387	—	$0	0	SEC↗
Lloyd Marcea Bland	Director	P Buy	2020-07-14	2020-07-15	10,000	$16.00	$160.0K	10,000	SEC↗
Hirsch David	Director	C Conversion	2020-07-14	2020-07-15	2,464,245	—	$0	2,464,245	SEC↗
Hirsch David	Director	P Buy	2020-07-14	2020-07-15	250,000	$16.00	$4.00M	2,714,245	SEC↗
Murphy Sean	Director, 10% Owner	C Conversion	2020-07-14	2020-07-15	1,168,985	—	$0	8,182,903	SEC↗
Murphy Sean	Director, 10% Owner	C Conversion	2020-07-14	2020-07-15	7,013,918	—	$0	7,013,918	SEC↗
Murphy Sean	Director, 10% Owner	C Conversion	2020-07-14	2020-07-15	690,124	—	$0	8,873,027	SEC↗
Murphy Sean	Director, 10% Owner	C Conversion	2020-07-14	2020-07-15	315,098	—	$0	9,188,125	SEC↗
Murphy Sean	Director, 10% Owner	P Buy	2020-07-14	2020-07-15	10,000	$16.00	$160.0K	10,000	SEC↗
Ostertag Eric	Chief Executive Officer	C Conversion	2020-07-14	2020-07-15	255,845	—	$0	629,194	SEC↗
Ostertag Eric	Chief Executive Officer	C Conversion	2020-07-14	2020-07-15	350,696	—	$0	350,696	SEC↗
Malin Corp plc	10% Owner	C Conversion	2020-07-14	2020-07-15	7,013,918	—	$0	7,013,918	SEC↗
Malin Corp plc	10% Owner	C Conversion	2020-07-14	2020-07-15	315,098	—	$0	9,188,125	SEC↗
Malin Corp plc	10% Owner	C Conversion	2020-07-14	2020-07-15	1,168,985	—	$0	8,182,903	SEC↗
Malin Corp plc	10% Owner	C Conversion	2020-07-14	2020-07-15	690,124	—	$0	8,873,027	SEC↗